Structure Therapeutics (GPCR) Total Liabilities (2022 - 2026)

Structure Therapeutics' Total Liabilities history runs 5 years deep, the most recent figure standing at $61.0 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 45.62% year-over-year to $61.0 million in Q1 2026; TTM through Mar 2026 was $61.0 million, a 45.62% increase from a year earlier, with the FY2025 full-year figure at $67.5 million, up 75.49% from the prior year.
• Total Liabilities slipped to $61.0 million in Q1 2026 per GPCR's latest filing, from $67.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $67.5 million in Q4 2025 and bottomed at $11.0 million in Q1 2023.
• The 5-year median for Total Liabilities is $32.7 million (2023), against an average of $35.5 million.
• Biggest YoY gain for Total Liabilities was 149.11% in 2024; the steepest drop was 32.48% in 2024.
• Year by year, Total Liabilities stood at $13.0 million in 2022, then soared by 123.3% to $29.1 million in 2023, then jumped by 32.48% to $38.5 million in 2024, then surged by 75.49% to $67.5 million in 2025, then fell by 9.64% to $61.0 million in 2026.
• Per Business Quant, the three latest GPCR Total Liabilities figures stand at $61.0 million (Q1 2026), $67.5 million (Q4 2025), and $62.1 million (Q3 2025).